For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| OMNI-canaloplasty Alone | The safety analysis population will contain all subjects for whom the OMNI (canaloplasty alone) is attempted | 0 | None | 0 | 5 | 3 | 5 | View |
| OMNI-canaloplasty + Trabeculotomy | The safety analysis population will contain all subjects for whom the OMNI (canaloplasty+trabeculotomy) is attempted | 0 | None | 0 | 1 | 1 | 1 | View |
| iStent Inject | The safety analysis population will contain all subjects for whom the iStent injectis attempted | 0 | None | 0 | 4 | 0 | 4 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| IOP elevation | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Anterior chamber inflammation | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Allergic conjunctivitis | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Tendinitis | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| COVID-19 infection | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |